Phase I study of TH-302, an investigational hypoxia-targeted drug, and dexamethasone in patients with relapsed/refractory multiple myeloma.
Irene M. Ghobrial
No relevant relationships to disclose
Jacob Laubach
No relevant relationships to disclose
Philippe Armand
No relevant relationships to disclose
Erica Boswell
No relevant relationships to disclose
Courtney Hanlon
No relevant relationships to disclose
Stacey Chuma
No relevant relationships to disclose
Esther Dawn Chu
Employment or Leadership Position - Threshold Pharmaceuticals
Stock Ownership - Threshold Pharmaceuticals
Damian Handisides
Employment or Leadership Position - Threshold Pharmaceuticals
Stock Ownership - Threshold Pharmaceuticals
Stew Kroll
Employment or Leadership Position - Threshold Pharmaceuticals
Stock Ownership - Threshold Pharmaceuticals
Barbara Hickingbottom
Employment or Leadership Position - Threshold Pharmaceuticals
Stock Ownership - Threshold Pharmaceuticals
Kenneth Carl Anderson
No relevant relationships to disclose
Paul Gerard Guy Richardson
No relevant relationships to disclose